On October 20, 2024, the China (Tianjin) International Biopharmaceutical Industry Expo (BIOME 2024) concluded successfully at the Tianjin National Convention and Exhibition Center. This grand event brought together renowned biopharmaceutical industry chain brands from home and abroad as well as top industry experts, scholars and enterprise representatives to jointly discuss industry achievements and future directions. ProteinT was invited to appear, attracting the attention of many attendees with its cutting-edge technologies and innovative products.
Highlights Revisited
At this conference, ProteinT showcased its two major precision health management products, MiMiTM and ZhiHangTM, and specially launched the [90% Off First-Try] campaign, allowing everyone to experience the transformative power of technology-driven health management at a great value, opening a new door to personalized health management and disease prevention for more people. At the same time, it opened up the opportunity of [First-Time Partner Recruitment] to industry partners, sincerely inviting like-minded enterprises and individuals to jointly advance the field of precision medicine. During the exhibition, precision clinical diagnosis and treatment solutions for tumors, cardiovascular and cerebrovascular diseases and other conditions based on proteomics and other multi-omics technologies, as well as various approved kit products, also attracted the attention and lingering of a large number of experts, scholars and peers.
A New Experience of Healthy Living
Partner Recruitment Is in Full Swing······
The conference has successfully concluded, but the discussion surrounding precision health management is far from over. We believe that as the relevant technologies continue to advance and improve, more and more people will benefit from more efficient and personalized health management services. ProteinT will continue to be committed to scientific research and innovation, and looks forward to joining hands with more partners to create the future together. See you next time!
